Neximmune

Developer of immunotherapeutics for cancer

placeGaithersburg, Maryland, United States calendar_todayFounded 2011 groups69 employees language neximmune.com

Registered entities

Innovation

8 patent families (5 granted) — focus: Human necessities, Chemistry & metallurgy, Physics & computing; filing pace slowing. Cited 531 times.

YearFilings
20141
20162
20173
20183
20193
20205
20215
20223
20235
20246
20253

Investor mix

15 investors on record; lead investors include New Enterprise Associates, ArrowMark Partners.

Investor typeCountShare
Venture capital853%
Private equity17%
Accelerator & incubator213%
Other / undisclosed427%
Coming soon